Drugs / Brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension
Brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01297517 | Feb 2011 → Mar 2012 | ocular hypertension, open-angle glaucoma | Alcon Research | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01297517 ↗ |
| Route | Topical | “Topical administration of study medication (fixed-combination brinzolamide, 1%, and brimonidine, 0.2%; brinzolamide, 1%; or brimonidine, 0.2%)” PMID 23579344 ↗ Jun 2013 |